First Case of VIM-1-like-Producing Pseudomonas putida Bacteremia in an Oncohematological Pediatric Patient in Italy

Antibiotics (Basel). 2023 Jun 9;12(6):1033. doi: 10.3390/antibiotics12061033.

Abstract

Bacterial infections caused by multidrug-resistant (MDR) Gram-negatives are of great concern worldwide, as they are frequently associated with high mortality and morbidity rates. To date, two cases of VIM-2 metallo-β-lactamase (MBL)-producing Pseudomonas putida bacteremia have been ever reported in France and Spain between 2004 and 2010. Here, we present the first case of VIM-1-like-producing P. putida isolated in blood culture collected from an oncohematological pediatric patient admitted to Bambino Gesù Children's Hospital (IRCCS) in Rome, Italy.

Keywords: Pseudomonas putida; VIM-1-like; metallo-β-lactamases; multidrug-resistant; pediatric patient; polymicrobial bacteremia.

Publication types

  • Case Reports

Grants and funding

This research was supported by EU funding within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007, INF-ACT) and by ANIA funding. This work was also supported by the Italian Ministry of Health with Current Research funds.